Matt Huentelman
Professor
Neurogenomics Division
Translational Genomics Research Institute
United States of America
Biography
Dr. Huentelman is a Professor in the Neurogenomics Division where his research interests center around the investigation of the "-omics" (genomics, transcriptomics, and proteomics) of neurological traits and disease. His laboratory's overarching goal is to leverage findings in these disciplines to better understand, diagnose, and treat human diseases of the nervous system. Dr. Huentelman joined TGen in July of 2004 after completing his doctoral work at the University of Florida's Department of Physiology and Functional Genomics at the McKnight Brain Institute where he investigated the application of gene therapy in the study and prevention of hypertension. His undergraduate degree is in Biochemistry from Ohio University's Department of Chemistry and Biochemistry at Clippinger Laboratories. Dr. Huentelman's career includes visiting researcher stints in Moscow, Russia at the MV Lomonosov Moscow State University "Biology Faculty" and in the United Kingdom within the University of Bristol's Department of Physiology.
Research Interest
(genomics, transcriptomics, and proteomics) of neurological traits and disease, gene therapy in the study and prevention of hypertension, Alzheimer's Disease
Publications
-
Structure-based discovery of a novel angiotensin-converting enzyme 2 inhibitor. Hypertension. 2004 Dec;44(6):903-6. Epub 2004 Oct 18.
-
Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. N Engl J Med. 2006 Mar 30;354(13):1370-7.
-
Hippocampal gene expression changes during age-related cognitive decline. Brain Res. 2009 Feb 23;1256:101-10.
-
A Frame-Shift Mutation in CAV1 Is Associated with a Severe Neonatal Progeroid and Lipodystrophy Syndrome. PLoS One. 2015 Jul 15;10(7):e0131797.
-
Rare Variants in Cardiomyopathy Genes Associated With Stress-Induced Cardiomyopathy. Neurosurgery. 2016 Jun;78(6):835-43.
